A better understanding of genetic epilepsy mechanisms is needed to develop precision therapies for patients. To shed light on these mechanisms, we are combining mouse and human pluripotent stem cell models. I will discuss our work modeling genetic epilepsies (SCN8A, PCDH19 and MECP2) using human pluripotent stem cell-derived 2-D neuronal and brain organoid cultures.